TWC
IMCR icon

TD Waterhouse Canada’s Immunocore IMCR Stock Holding History

TD Waterhouse Canada’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-7,411
Closed -$212K – 2053
2025
Q1 		$212K Buy
7,411
+44
+0.6% +$1.32K ﹤0.01% 780
2024
Q4 		$217K Buy
7,367
+137
+2% +$4.33K ﹤0.01% 775
2024
Q3 		$226K Buy
7,230
+6,348
+720% +$231K ﹤0.01% 753
2024
Q2 		$32.1K Buy
882
+133
+18% +$6.78K ﹤0.01% 1124
2024
Q1 		$47.5K Buy
+749
New +$51.4K ﹤0.01% 1061

Other funds holding IMCR

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

TD Waterhouse Canada's IMCR Position: Q2 2025 in Review

TD Waterhouse Canada sold out of Immunocore (IMCR) in Q2 2025, closing a stake of 7,411 shares — an estimated $212K sold.

TD Waterhouse Canada first reported a position in IMCR in Q1 2024 and held it in 5 quarters. The position peaked at $226K in Q3 2024. 133 funds tracked by Wall St. Rank hold IMCR as of Q2 2025.

  • TD Waterhouse Canada reported no remaining Immunocore position as of Q2 2025 after selling out during the quarter.
  • TD Waterhouse Canada sold 7,411 Immunocore shares in Q2 2025, an estimated $212K.
  • TD Waterhouse Canada first reported a position in Immunocore in Q1 2024 and held it in 5 quarters.
  • TD Waterhouse Canada's Immunocore position peaked at $226K in Q3 2024.
  • 133 funds tracked by Wall St. Rank held Immunocore as of Q2 2025.

Based on TD Waterhouse Canada's 13F filing for Q2 2025, filed 11 Aug 2025.